CN Stock MarketDetailed Quotes

600422 KPC Pharmaceuticals, Inc.

Watchlist
  • 15.75
  • 0.000.00%
Not Open Nov 8 15:00 CST
11.92BMarket Cap26.74P/E (TTM)

KPC Pharmaceuticals, Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KPC Pharmaceuticals, Inc. Q3 2024 Earnings Date

Currency：CNYOct 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.90B
--
+3.41%
Net Income
--
156.81M
--
-5.37%
Analyst Rating
Strong Buy

Nov 10, 2024

KPC Pharmaceuticals, Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/FY -- / 9.486B --
-- 2024/FY -- / 8.237B --
Mar 22, 2024 2023/FY 7.703B / 8.380B --
Mar 23, 2023 2022/FY 8.282B / 8.537B --
Mar 19, 2022 2021/FY 8.254B / 9.065B --
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.486B--
--2024/FY-- / 8.237B--
Mar 22, 20242023/FY7.703B / 8.380B--
Mar 23, 20232022/FY8.282B / 8.537B--
Mar 19, 20222021/FY8.254B / 9.065B--

Unlock Free Earnings Estimates

KPC Pharmaceuticals, Inc. Earnings Reports

  • KPC Group Report for the Third Quarter of 2024

    Oct 26 00:00

  • kpc pharmaceuticals, inc. 2024 semi-annual report

    Aug 23 00:00

  • Summary of kpc pharmaceuticals, inc.'s 2024 interim report

    Aug 23 00:00

  • KPC Group Report for the First Quarter of 2024

    Apr 20 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 10, 2024

    Strong Buy

    • Strong Buy

      81.82%

    • Buy

      18.18%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data